Titel: Stem Cells: From Tissue Engineering and Regenerative Medicine to Policy

Termin: 19.4.2006, 12:30 Uhr, bis 20.4.2006, 17:15 Uhr

Veranstaltungsort:
Robinson College,
Cambridge, UK

Referenten: Sir David King (Chief Scientific Advisor) *** Stephen Minger (King’s College London) *** Peter Andrews (University of Sheffield) *** Miodrag Stojkovic (Centro de Investigación Principe Felipe, Valencia, Spain) *** Christine Mummery (University of Utrecht) *** Curt Civin (John Hopkins University, Baltimore, USA) *** Roger Pedersen (University of Cambridge) *** Fiona Watt (London Research Institute and University of Cambridge) *** Julia Polak (Imperial College London) *** Sarah Cunningham Burley (Innogen, University of Edinburgh) *** Brian Salter (University of East Anglia) *** Suzi Leather (Human Fertilisation and Embryology Authority (HFEA)) *** Catherine Waldby (University of New South Wales, Australia) *** David Coles (DG Research) *** Andrew Webster (University of York) *** Linda Hogle (University of Wisconsin) *** Paul Martin (University of Nottingham) *** Martin Evans (University of Cardiff) *** Barbara Prainsack (University of Vienna) *** Glyn Stacey (UK Stem Cell Bank) *** Bob Nerem (Georgia Institute of Technology, Atlanta, USA) *** Brenda Sandmaier (Fred Hutchinson Cancer Research Centre, Washington, USA) *** Kevin Shakesheff (University of Nottingham) *** Rajesh Chopra (AstraZeneca) *** Chris Mason (University College London) *** Gareth Roberts (Novathera) *** Sheila MacNeil (University of Sheffield) *** Gus McGrouther (University of Manchester) *** Giorgio Terenghi (University of Manchester) *** John Sinden (ReNeuron) *** Edward Yeh (University of Texas, USA) *** Anne McLaren (University of Cambridge)

Weitere Informationen:
http://www.eescn.org.uk/symposium/

Kurzbeschreibung: New knowledge from research into stem cell biology offers a number of insights into how cells develop and specialise which has meant that work in this field has huge potential to benefit human health. Stem cell-based therapies and technologies may be used to treat a variety of conditions ranging from degenerative diseases such as multiple sclerosis and Parkinson's disease to the repair of damaged bone or tissue.

The translation of breakthroughs in stem cell science into tangible medical advances requires not just researchers involved in fundamental research, but those with expertise in clinical medicine, tissue engineering, bioprocessing and drug development. Additionally, a range of regulatory, legal and policy issues must also be addressed to ensure that stem cell medicine develops within an appropriate framework that maintains public confidence.

The East of England Stem Cell Network is please to invite you to an international symposium that reflects a diversity of interests. Stem Cells: From Tissue Engineering and Regenerative Medicine to Policy will take place on 19th- 20th April 2006, at Robinson College, Cambridge, UK. Over two hundred delegates will be able to hear about the latest scientific research taking place in Cambridge, and across the country, as well as the most recent national and international perspectives on the governance and regulation of this field.

This international symposium covering basic and translational stem cell research, as well as issues of regulation and policy has been organised by the University of Cambridge, Imperial College London and the University of East Anglia with the support of the East of England Stem Cell Network.

Kontakt: Mrs Helen Wilson
EESCN Administrator
East of England Stem Cell Network
Cambridge Genetics Knowledge Park
Strangeways Research Laboratory
Worts Causeway
Cambridge CB1 8RN
United Kingdom
Tel.: +44 - 12 - 23 74 13 26
Fax: +44 - 12 - 23 74 02 00
helen.wilson@srl.cam.ac.uk
http://www.eescn.org.uk/

Veranstalter: East of England Stem Cell Network, University of Cambridge, Imperial College London, UEA Norwich, Albion Innovations

Schlagworte: Embryonale Stammzellen, Gesundheitswesen, Krankheit, Organ-/Gewebetransplantation, Pharmazeutik